Gideon Blumenthal has been appointed acting deputy office director of the Office of Hematology and Oncology Products at FDA. Blumenthal is a medical oncologist and serves as the associate director of precision therapeutics in OHOP. The appointment was announced by Richard Pazdur, director of the Oncology Center of Excellence and OHOP acting director. Blumenthal previously...
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe